Novo Nordisk: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Menghapus Nn_logo_rgb_blue_large.png karena telah dihapus dari Commons oleh King of Hearts; alasan: Copyright violation; see c:Commons:Licensing (F1): Non-free logo |
Rescuing 0 sources and tagging 1 as dead.) #IABot (v2.0.9.2 |
||
Baris 9:
| industry = [[Farmasi]], [[Perawatan kesehatan]]
| products = [[Ozempic]], [[Ryzodeg]], [[Victoza]], [[NovoEight]], [[Activella]], [[Novolin]], [[Levemir]], [[NovoSeven]], [[Norditropin]], [[Tresiba]], [[Xultophy]], [[NovoRapid]], [[Fiasp]], [[Saxenda]] <br/>
| revenue = {{Increase}} [[Krona Denmark|DKK]] 122,02 miliar <small>(2019)<ref name="AR2019">{{cite web |url=https://annualreport2019.novonordisk.com/section/performance_highlights |title=Annual Report 2019 |publisher=Novo Nordisk |access-date=2020-12-24 }}{{Pranala mati|date=November 2022 |bot=InternetArchiveBot |fix-attempted=yes }}</ref></small>
| operating_income = {{Increase}} DKK 52,483 miliar <small>(2019)<ref name="AR2019" /></small>
| net_income = {{Increase}} DKK 38,951 miliar <small>(2019)<ref name="AR2019" /></small>
| |||
